Tirzepatide
Dual GIP/GLP-1 receptor agonist. Mounjaro / Zepbound. More potent fat loss than Semaglutide in clinical trials. Increasingly popular in bodybuilding for cutting.
Overview
Dual GIP/GLP-1 receptor agonist. Mounjaro / Zepbound. More potent fat loss than Semaglutide in clinical trials. Increasingly popular in bodybuilding for cutting.
Significant appetite suppression, improves fasting glucose and HbA1c (more potently than Semaglutide), improves lipid profile, may mildly affect liver enzymes (typically improvement), can elevate amylase/lipase, reduces CRP and inflammatory markers
Compound Guide
Structure: Dual-acting peptide — agonist at both GIP (Glucose-dependent Insulinotropic Polypeptide) and GLP-1 receptors. The dual mechanism provides more potent metabolic effects than GLP-1 alone.
Dosage:
- Weight loss (titrate up): 2.5mg/week x4 weeks → 5mg/week x4 weeks → 7.5mg/week → 10mg/week → 12.5mg/week → 15mg/week
- Bodybuilding cut: 5-10mg/week (titrate based on appetite suppression and tolerability)
Administration:
- SubQ injection once weekly, abdomen/thigh/upper arm
- Titrate slowly — at least 4 weeks at each dose level to minimise GI sides
Key Notes:
- Clinical trials show greater weight loss than Semaglutide at maximal doses
- Same GI side effect profile as Semaglutide but can be more pronounced during titration
- Dual GIP/GLP-1 mechanism may better preserve muscle mass compared to GLP-1-only agonists (emerging data)
- Extremely potent appetite suppression — some users struggle to eat enough protein
- Maintain resistance training and high protein intake (>2g/kg) to preserve muscle
- Monitor: fasting glucose, HbA1c, lipid panel, amylase/lipase, liver enzymes
- Same pancreatitis risk considerations as Semaglutide
Usage History
Frequently Asked Questions
Related Articles
Does 5-Amino-1MQ Actually Burn Fat? (No Human Trials Yet)
5-amino-1MQ is an NNMT inhibitor sold for fat loss and NAD+. Here's the real evidence, honest dosing, and the bloodwork to run on it.
Does Your DNA Decide How You Metabolize Steroids and Meds?
Use your 23andMe raw data to read how you metabolize steroids, tamoxifen, statins and GLP-1 drugs. Free, in-browser, nothing uploaded.
How Much Muscle You Lose Cutting on Retatrutide
TRIUMPH-1 showed 28.3% weight loss. Here's how much was muscle, what DEXA data predicts for athletes, and how to preserve muscle on a retatrutide cut.
Retatrutide Bloodwork: The Triple Agonist Monitoring Guide
What to test on retatrutide. Monitoring protocol for the GLP-1/GIP/glucagon triple agonist: liver, thyroid, pancreas, glucose, and muscle markers.
Quick Reference
Category
GLP-1
Half-Life
5 days
Detection Time
N/A